Commercial brand names

A commercially interesting low calorie fat has been produced from sucrose. Proctor Gamble has patented a mixture of penta- to octafatty acid ester derivatives of sucrose under the brand name Olestra. It was approved by the FDA in January 1996 for use as up to 100% replacement for the oil used in preparing savory snacks and biscuits. Olestra, a viscous, bland-tasting Hquid insoluble in water, has an appearance and color similar to refined edible vegetable oils. It is basically inert from a toxicity point of view as it is not metabolized or absorbed. It absorbs cholesterol (low density Hpoprotein) and removes certain fat-soluble vitamins (A, D, E, and K). Hence, Olestra has to be supplemented with these vitamins. No standard LD q tests have been performed on Olestra however, several chronic and subchronic studies were performed at levels of 15% in the diet, and no evidence of toxicity was found. No threshold limit value (TLV), expressed as a maximum exposure per m of air, has been estabhshed, but it is estimated to be similar to that of an inert hpid material at 5 mg/m. ... 

Chemindex plus. This database contains 8000 pharmaceutical ingredients linked to 300,000 preparations. Chemindex plus [66] can be interrogated at the national or international level. It covers compounds available in 55 countries recording their brand name, local manufacturer, launch date, therapeutic class, and base forms. This product is commercially available from IMS HEALTH Global Services. 

Sodium Hypochlorite Solution (household bleach) can be used against both chemical and biological agents. It is effective and fast-acting against blister and V nerve agents, but requires a contact time of ten to fifteen minutes for all biological materials. It is available in food stores as a 5 percent solution under various brand names, and as a 14 to 10 percent solution at commercial laundries. Undiluted, household bleach is harmful to skin and... 

Minor Recommendation 1 Clarify that commercial marketing includes the first generic applicant s marketing of the brand-name product. 

The Court of Appeals determined that the dismissal for lack of case or controversy was, in fact, a court decision, because the brand-name company indicated that the second generic applicant s ANDA did not infringe the relevant patent. As a result, the dismissal activated the court decision trigger. Such a rule eliminates the potential for a bottleneck created by a first generic applicant that does not exercise its commercial marketing rights. 

For 15 of the 29 drug products where the brand-name company did not sue the first generic applicant, the generic applicant began commercial marketing soon after FDA approval and prior to patent expiration. In 6 cases, the FDA has not approved the generic applicant s ANDA as of June 1, 2002, and the patents have not yet expired. 

In one pending case, the FDA determined that the brand-name company failed to submit the required information for a particular patent in a timely manner. Therefore, the generic applicant was not required to submit a patent certification to address that patent, the 30-month stay was dissolved, and the FDA subsequently approved the ANDA. Commercial patent litigation was still pending as of June 1, 2002, however, and the generic applicant has not yet entered the market. 

In 8 of the 19 instances, the brand-name company and the generic applicant settled the patent litigation and the generic applicant s commercial marketing triggered the 180-day exclusivity. These 8 settlements can be grouped into 4 categories ... 

Although the 180-day exclusivity has run in these 2 instances, there is some uncertainty as to whether commercial marketing by the first generic applicant of the brand-name company s product will always activate the commercial marketing trigger. 

Chemical modulation of the surface conductivity is the principle of operation of some of the most commercially successful chemical sensors, the high temperature semiconducting oxide sensors. They are known by their brand name Figaro sensors. They are discussed in detail in Section 8.2.2.1. The reason for their commercial success lies in the fact that their performance and cost match exactly the specific practical needs of many applications, particularly those of the automotive industry. They have been described in great detail, from the point of view of both the underlying physics and chemistry (Morrison, 1994 Logothetis, 1987). 

The product name and the brand name under which the commercial feed is distributed. 

The CDP was commercially developed into a processing machine by the Farrel Corporation of Ansonia, CT, USA, under the brand name Diskpack. 

---